The landscape of diabetes care is advancing with the arrival of GLP-1 patches . These novel patches offer a likely simpler alternative to needle administrations for individuals living with diabetes 2. These patches deliver GLP-1 medication directly through the dermis , avoiding the necessity for daily injections and perhaps increasing compliance .